Treatment of COVID-19

Treatment of COVID-19

Hydroxychloroquine and azithromycin as a treatment of COVID-19

18 mars 2020

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial

pdf article to download: Hydroxychloroquine_final_DOI_IJAA

Percentage of patients with PCR-positive nasopharyngeal samples from inclusion to day 6 post-inclusion in COVID-19 patients treated with hydroxychloroquine only, in COVID-19 patients treated with hydroxychloroquine and azithomycin combination, and in COVID-19 control patients.

Please cite this work as Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. International Journal of Antimicrobial Agents – In Press 17 March 2020 – DOI : 10.1016/j.ijantimicag.2020.105949